Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit

Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.

The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.